Related Experiment Video
Updated: Jun 10, 2026

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
Palliative medicine trainees and their mandatory oncology module
1Mary Potter Hospice, Wellington, New Zealand. amandalanders@paradise.net.nz
Abstract:
Palliative medicine trainees are currently required to complete 36 months of core and non-core training, including a 6-month oncology module. There are presently few published data from palliative medicine trainees regarding the structure and appropriateness of their curriculum. The aim of this study was to evaluate skills related to the Royal Australasian College of Physicians essential learning objectives and the experiences gained by the individuals during their oncology training. An investigator-designed questionnaire was emailed out to all current Australasian trainees or first year consultants. A 45% response rate was achieved. Women were significantly more negative in their responses to the improvement of communication skills and the understanding of ethics. Chapter trainees rated improved leadership and future management skills lower than other respondents. Fifty-eight per cent of the respondents believed the oncology module should remain mandatory. Although valuable, a more tailored and flexible approach to this part of training should be considered.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Continuing Care
